Advice
in the absence of a submission from the holder of the marketing authorisation:
triptorelin pamoate (Salvacyl®) is not recommended for use within NHS Scotland.
Indication under review: reversible reduction of testosterone to castrate levels in order to decrease sexual drive in adult men with severe sexual deviations.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHS Scotland.
Download detailed advice39KB (PDF)
Medicine details
- Medicine name:
- triptorelin pamoate (Salvacyl)
- SMC ID:
- 796/12
- Indication:
- Reversible reduction of testosterone to castrate levels in order to decrease sexual drive in adult men with severe sexual deviations.
- Pharmaceutical company
- Ipsen Ltd
- BNF chapter
- Endocrine system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 11 June 2012